NOVAVAX, INC.
502086-9508ActiveDeveloping innovative protein-based vaccines using proprietary adjuvant technology.
Yleiskatsaus
- 0
- Työntekijät
- 1–2.5milj SEK
- Liikevaihto
- 2021
- Perustettu
Avainpäättäjät
Rick Crowley
Executive Vice President, Chief Operations Officer
Jane Shershenovich
Vice President, Chief Intellectual Property Counsel, Legal
Jim Kelly
Executive Vice President, Chief Financial Officer and Treasurer
Elaine O’Hara
Executive Vice President, Chief Strategy Officer
+17 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Novavax is a biotechnology company dedicated to developing life-saving vaccines to prevent serious illnesses globally. Its core strength lies in a proprietary technology platform combining recombinant protein-based nanoparticles with their specialized Matrix-M adjuvant. This platform is designed to...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Tuntematon
- Oikeudellinen muoto
- Utländsk juridisk person
- ALV-numero
- SE502086950801
Päättäjät
21 yhteystietoa FunnelfeedrissäRick Crowley
Executive Vice President, Chief Operations Officer
Jane Shershenovich
Vice President, Chief Intellectual Property Counsel, Legal
Jim Kelly
Executive Vice President, Chief Financial Officer and Treasurer
Elaine O’Hara
Executive Vice President, Chief Strategy Officer
Rachel King
Director
Ian Watkins
Executive Vice President, Chief Human Resources Officer
David Mott
Director
Gretchen Earle
Senior Director, Global Program Management
Rick Rodgers, MBA
Director
Robert Walker, MD
Senior Vice President, Chief Medical Officer
Ruxandra Draghia-Akli, MD, PhD
Executive Vice President, Head of Research & Development
Richard Douglas, PhD
Director
Margaret G. McGlynn, R. Ph.
Chairman of the Board of Directors
Silvia Taylor
Executive Vice President, Chief Corporate Affairs Officer and Head of Novavax Sweden
Troy Morgan, JD
Senior Vice President Deputy General Counsel & Chief Compliance Officer
Gregg Alton
Director
Mark Casey
Executive Vice President, Chief Legal Officer
John Shiver, PhD
Director
Charles Newton
Director
John C. Jacobs
President and Chief Executive Officer
Henrietta Ukwu, MD
Executive Vice President, Chief Regulatory Officer
Samankaltaiset yritykset
20 samankaltaista yritystä FunnelfeedrissäAbera Bioscience AB
Developing next-generation nasal vaccines using modular OMV platform technology.
VALNEVA SWEDEN AB
Specialty vaccine company developing, manufacturing, and commercializing prophylactic vaccines.
Bavarian Nordic Sweden AB
1–4 työntekijätPioneering global developer and manufacturer of life-saving vaccines.
NOVO NORDISK HEALTH CARE AG
0 työntekijätGlobal leader developing innovative medicines for chronic diseases.
ARGENX BV
1–4 työntekijätEngineering life-changing immunology solutions for severe autoimmune diseases.
Selaa lisää
Kysymyksiä yrityksestä NOVAVAX, INC.
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo